DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

Galena Biopharma, Inc. (NASDAQ: GALE)

3.04 0.15 (5.01%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GALE $3.04 5.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.00
Previous Close $2.90
Daily Range $2.93 - $3.07
52-Week Range $1.65 - $7.77
Market Cap $358.8M
P/E Ratio -3.81
Dividend (Yield) $0.00 (0.0%)
Volume 4,097,888
Average Daily Volume 4,314,583
Current FY EPS -$0.28

Sector

Healthcare

Industry

Drugs

Galena Biopharma, Inc. (GALE) Description

Galena Biopharma Inc is a biotechnology company focused on discovering developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. Website: http://www.galenabiopharma.com/

News & Commentary

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

Galena Gives Sales Team Another Useless Product to Promote

Sector Update: Health-Care Shares Higher Pre-Market

Sector Update: Health Care

Galena Biopharma Enters Into Definitive Agreement To License U.S. Rights for Zuplenz Oral Soluble Fi

Galena Biopharma Enters Into Definitive Agreement To License U.S. Rights for Zuplenz Oral Soluble Film - Will Pay $5M In Cash & Stock

Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock

Sector Update: Shares Flat Pre-Market; Agenus Soars 21% on Phase 2 Trial

Sector Update: Healthcare

Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal

Sector Update: Share Higher Pre-Market; GW Pharmaceuticals Rallies 6% on Results from Study on Epile

Sector Update: Share Higher Pre-Market; GW Pharmaceuticals Rallies 6% on Results from Study on Epilepsy Treatment

Sector Update: Healthcare Healthcare

See More GALE News...

GALE's Top Competitors

GALE $3.04 (5.01%)
Current stock: GALE
AMGN $122.01 (0.74%)
Current stock: AMGN
GILD $90.34 (1.13%)
Current stock: GILD
BIIB $337.60 (11.17%)
Current stock: BIIB